Roche Holding AG

Roche Holding AG

Roche Holding AG

Date Founded



Grenzacherstrasse 124,Basel, Basel-Stadt (Basle Town) 4070

Type of Company


Employees (Worldwide)



Hospitals & Patient Services
Wholesale: Consumer Non-Durables/Sundries
IT Consulting & Services
Holding Companies
Medical Support Services

Company Description

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Contact Data
Trying to get in touch with decision makers at Roche Holding AG? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial & Information Technology Officer

General Counsel

Chairman & Chief Executive Officer of Chugai

Secretary-Executive Committee & Head-Chief Executive Officer Office

Head of Group Communications

Global Head of Pharma Partnering


Board of Directors

Director at Chugai Pharmaceutical Co., Ltd.

Treasurer & Director at Fondation Auxiliaire du Conservatoire botanique de la Ville de

Chief Executive Officer at Roche Holding AG

Executive Director, Chief Financial Officer & Chief Operating Officer at Burberry Group Plc

Venture Partner at LSP Management Group BV

Former Director at Roche Holding AG

Group Chief Executive Officer at Swiss Life Holding AG

Venture Partner Healthcare at Qiming Venture Partners Ltd.

Director at L'Oréal SA

Non-Executive Independent Deputy Chairman of the Board of Directors at Bucher Industries AG

Paths to Roche Holding AG
Potential Connections via
Relationship Science
Roche Holding AG
Owners & Shareholders
Details Hidden

NBIM is an active, conservative manager with a long-term outlook that aims to achieve the highest possible return on the Government Pension Fund Global within the investment mandate set by the Ministry of Finance, which owns the fund on behalf of the Norwegian people. The ministry determines the fund’s investment strategy, following advice from among others, NBIM and discussions in Parliament. The firm’s mandate defines the investment universe and the fund's strategic reference index. The Ministry of Finance has on a regular basis transferred capital to the fund from the Norwegian state's petroleum revenues. The fund's capital is invested abroad, to avoid overheating the Norwegian economy and to shield it from the effects of oil price fluctuations. The fund invests in international equity and fixed-income markets and real estate. It is invested in most markets, countries and currencies to achieve broad exposure to global economic growth. The investments are to produce a high long-term return. NBIM aims to achieve this this with an acceptable level of risk, as a responsible investor and through an efficient organization.

Details Hidden

UBS Asset Management Switzerland offers investment capabilities across all major traditional and alternative asset classes.

Details Hidden

CSAM Schweiz is an active manager which invests in equities and fixed-income across sectors and market-caps.

Recent Transactions
Details Hidden

Roche Holding AG purchases GenMark Diagnostics Inc.

Details Hidden

Roche Holding AG purchases Enterprise Therapeutics Ltd. /TMEM16A potentiator portfolio from Enterprise Therapeutics Ltd.

Details Hidden

Roche Holding AG purchases Inflazome Ltd.

Transaction Advisors
Legal Advisor

Advised onRoche Holding AG purchases Genentech, Inc.

Investment Advisor

Advised onKoninklijke DSM NV purchases Roche Holding AG /Roche Vitamins Unit from Roche Holding AG

Investment Advisor

Advised onRoche Holding AG purchases InterMune, Inc.

Legal Advisor

Advised onRoche Holding AG purchases InterMune, Inc.

Legal Advisor

Advised onRoche Holding AG purchases InterMune, Inc.

Legal Advisor

Advised onRoche Holding AG purchases Genentech, Inc.

Advisors & Consultants

Professor-Emeritus at Stanford University - School of Medicine


Executive Vice President & Chief Investment Officer at Connecticut Innovations, Inc.


Founder at Lassiter Consulting


bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The firm develops testing. detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.

AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Enterprise Value / Sales
Enterprise Value EBITDAOperating
TEVNet Income
Debt TEV
Three Year Compounded Annual Growth Rate Of Revenue
Total Equity
Net Profit
Total Debt
Details Hidden

Vaccibody AS is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.

Details Hidden

Wagmo, Inc. operates as a pet wellness company. The firm offers monthly wellness plan that reimburses members for routine care services that keep pets healthy. It helps pet parents get the best care for dogs and cats by offering plans that cover the day-to-day essentials, including routine and preventative expenses such as annual exams, vaccines, and grooming. The company was founded by Christie Horvath and Ali Foxworth and is headquartered in Brooklyn, NY.

Details Hidden

Carbon Health Medical Group, Inc. engages in the provision of healthcare solutions. It develops platform that supports ongoing care management and virtual appointments. The company was founded by Eren Bali, Caesar Djavaherian, Tom Berry, and Greg Burrell and is headquartered in San Francisco, CA.

Details Hidden

Chairman at Jello Labs, Inc.

Details Hidden

Partner at Lowenstein Sandler LLP

Details Hidden

General Partner, Investing at Andreessen Horowitz LLC

Alexandria Real Estate Equities, Inc. Trusts & Funds | Pasadena, CA

Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust. It engages in the ownership, operation, development, and redevelopment of life science and technology properties. The firm also provides a space for lease to the life science and technology industries, which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Xenon Pharmaceuticals, Inc. Medical Support Services | Burnaby, Canada

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Exelixis, Inc. Hospitals & Patient Services | South San Francisco, CA

Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing our first product, COMETRIQ, from discovery to market, we have established an effective and integrated infrastructure that encompasses the entire biopharmaceutical development continuum. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.

Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Roche Holding AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Roche Holding AG's profile does not indicate a business or promotional relationship of any kind between RelSci and Roche Holding AG.